Mark R. Hellberg

964 citations

28 papers · 685 indexed · h-index 16

Co-authors: Marsha A. McLaughlin Tom R. Dean Jesse A. May Najam A. Sharif Naj Sharif Verney L. Sallee Louis DeSantis Paul W. Zinke
Topics: Glaucoma and retinal disorders (13 papers)Phytochemistry and Biological Activities (4 papers)Retinal Development and Disorders (4 papers)
Cited by: Ophthalmology Neurology Organic Chemistry
Journals: Journal of the American Chemical Society Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States China Canada

In The Last Decade

Mark R. Hellberg

28 papers receiving 660 citations

Peers

Countries citing papers authored by Mark R. Hellberg

Since Specialization

Citations

This map shows the geographic impact of Mark R. Hellberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Hellberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Hellberg more than expected).

Fields of papers citing papers by Mark R. Hellberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Hellberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Hellberg. The network helps show where Mark R. Hellberg may publish in the future.

Co-authorship network of co-authors of Mark R. Hellberg

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Hellberg. A scholar is included among the top collaborators of Mark R. Hellberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Hellberg. Mark R. Hellberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rapid Identification of Novel Inhibitors of the Human Aquaporin‐1 Water Channel 2015 ·Chemical Biology & Drug Design ·Rajkumar V. Patil,Shouxi Xu,Alfred N. Van Hoek,(unknown),(unknown),Jesse A. May,Mark R. Hellberg,Najam A. Sharif,Martin B. Wax,(unknown),Grant Carr,T Brittain,Peter de Nully Brown,(unknown),Sindhu Kumari,Kulandaiappan Varadaraj,Alok K. Mitra	19
2	In vivo optimization of 2,3-diaminopyrazine Rho Kinase inhibitors for the treatment of glaucoma 2014 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Jennifer Ward,Curtis R. Kelly,(unknown),Marsha A. McLaughlin,(unknown),(unknown),(unknown),Naj Sharif,Mark R. Hellberg,(unknown),Iok-Hou Pang,Keith D. Combrink	14
3	BK2A78: A novel non-peptide bradykinin B2 agonist lowers intraocular pressure (IOP) in ocular hypertensive cynomolgus monkeys. 2013 ·Investigative Ophthalmology & Visual Science ·Ganesh Prasanna,Naj Sharif,(unknown),Mark R. Hellberg,(unknown),(unknown),Daniel A. Scott,Curtis R. Kelly,Iok‐Hou Pang,Keith D. Combrink	2
4	Benzothiophene containing Rho kinase inhibitors: Efficacy in an animal model of glaucoma 2010 ·Bioorganic & Medicinal Chemistry Letters ·Robert L. Davis,Mehmet Kahraman,Thomas J. Prins,(unknown),(unknown),(unknown),Charmagne Cayanan,Elisabeth Gardiner,Marsha A. McLaughlin,Abbot F. Clark,Mark R. Hellberg,Andrew K. Shiau,Stewart A. Noble,Allen Borchardt	21
5	Agonists at the Serotonin Receptor (5-HT_1A) Protect the Retina from Severe Photo-Oxidative Stress 2010 ·Investigative Ophthalmology & Visual Science ·R.J. Collier,(unknown),Elizabeth A. Martin,Olga Dembinska,Mark R. Hellberg,(unknown),Michael A. Kapin,Carmelo Romano	56
6	Water-soluble PDE4 inhibitors for the treatment of dry eye 2010 ·Bioorganic & Medicinal Chemistry Letters ·Steven P. Govek,Guy Oshiro,John V. Anzola,Clay Beauregard,Jasmine Chen,(unknown),Daniel A. Gamache,Mark R. Hellberg,(unknown),(unknown),John C. Liao,James W. Malecha,Lena Staszewski,David J. Thomas,John M. Yanni,Stewart A. Noble,Andrew K. Shiau	16
7	2,3-Diaminopyrazines as rho kinase inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Alan J. Henderson,Mark Hadden,Cheng Guo,(unknown),(unknown),Mark R. Hellberg,(unknown),Marsha A. McLaughlin,Naj Sharif,(unknown),(unknown)	30
8	Discovery of 13-oxa prostaglandin analogs as antiglaucoma agents: Synthesis and biological activity 2008 ·Bioorganic & Medicinal Chemistry ·(unknown),Mark R. Hellberg,Najam A. Sharif,Marsha A. McLaughlin,Gary W. Williams,Daniel A. Scott,(unknown)	9
9	Novel benzodifuran analogs as potent 5-HT2A receptor agonists with ocular hypotensive activity 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Suchismita Mohapatra,Peter G. Klimko,Mark R. Hellberg,Jesse A. May,Curtis R. Kelly,Gary W. Williams,Marsha A. McLaughlin,Najam A. Sharif	28
10	A STUDY OF THE ENHANCED CORNEAL PENETRATION OF MOXIFLOXACIN 2004 ·Investigative Ophthalmology & Visual Science ·(unknown),(unknown),Jingyu Liao,(unknown),Mark R. Hellberg	4
11	15-Fluoro prostaglandin FP agonists: a new class of topical ocular hypotensives 2004 ·Bioorganic & Medicinal Chemistry ·Peter G. Klimko,Mark R. Hellberg,Marsha A. McLaughlin,Najam A. Sharif,(unknown),Gary W. Williams,(unknown),John C. Liao	18
12	AL-12182, a novel 11-oxa prostaglandin analog with topical ocular hypotensive activity in the monkey 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Mark R. Hellberg,Najam A. Sharif,Marsha A. McLaughlin,Gary W. Williams,Daniel A. Scott,David J. Earnest,(unknown),William Dean,(unknown),Michael S. Gaines,(unknown),Peter G. Klimko	7
13	β-Oxygenated Analogues of the 5-HT_2ASerotonin Receptor Agonist 1-(4-Bromo-2,5-dimethoxyphenyl)-2-aminopropane 2004 ·Journal of Medicinal Chemistry ·Richard A. Glennon,(unknown),Nantaka Khorana,Richard Young,Jesse A. May,Mark R. Hellberg,Marsha A. McLaughlin,Najam A. Sharif	16
14	The Hydrolysis of the Prostaglandin Analog Prodrug Bimatoprost to 17-Phenyl-trinor PGF _{2 α} by Human and Rabbit Ocular Tissue 2003 ·Journal of Ocular Pharmacology and Therapeutics ·Mark R. Hellberg,(unknown),(unknown),Peter G. Klimko,Tom R. Dean,Gustav Graff	39
15	Characterization of the In Vitro Anti-inflammatory Activity of AL-5898 and Related Benzopyranyl Esters and Amides 2003 ·Inflammation ·(unknown),Milton T. Brady,Lori K. Weimer,Mark R. Hellberg,J. C. Nixon,Gustav Graff	1
16	Evaluation of the Ocular Hypotensive Response of Serotonin 5-HT1A and 5-HT2 Receptor Ligands in Conscious Ocular Hypertensive Cynomolgus Monkeys 2003 ·Journal of Pharmacology and Experimental Therapeutics ·Jesse A. May,Marsha A. McLaughlin,Najam A. Sharif,Mark R. Hellberg,Thomas Dean	50
17	3-Oxa-15-cyclohexyl prostaglandin DP receptor agonists as topical antiglaucoma agents 2002 ·Bioorganic & Medicinal Chemistry ·Mark R. Hellberg	17
18	Preclinical Efficacy of Travoprost, a Potent and Selective FP Prostaglandin Receptor Agonist 2001 ·Journal of Ocular Pharmacology and Therapeutics ·Mark R. Hellberg,Verney L. Sallee,Marsha A. McLaughlin,Naj Sharif,Louis DeSantis,Tom R. Dean,Paul W. Zinke	96
19	A preliminary investigation of Mesoionic Xanthine analogues as inhibitors of platelet aggregation 2000 ·Bioorganic & Medicinal Chemistry ·Mark R. Hellberg,James F. Stubbins,Richard A. Glennon	12
20	Evaluation of AL-05712 and AL-05741 as Thioltransferase Mimics for the Prevention and Recovery of Pre-Cataractous Changes in Lens 1998 ·Journal of Ocular Pharmacology and Therapeutics ·Jaime E. Dickerson,Mark R. Hellberg,Marjorie F. Lou	2

About Mark R. Hellberg

Mark R. Hellberg is a scholar working on Ophthalmology, Toxicology and Sensory Systems, having authored 28 papers that have together received 685 indexed citations. Recurring topics across this work include Glaucoma and retinal disorders (13 papers), Phytochemistry and Biological Activities (4 papers) and Retinal Development and Disorders (4 papers). The work is most often cited by research in Ophthalmology (320 citations), Neurology (72 citations) and Organic Chemistry (189 citations). Mark R. Hellberg has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Marsha A. McLaughlin, Tom R. Dean, Jesse A. May, Najam A. Sharif, Naj Sharif, Verney L. Sallee, Louis DeSantis, Paul W. Zinke, John C. Liao and Peter G. Klimko. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact